1967
DOI: 10.1128/jb.93.6.1758-1761.1967
|View full text |Cite
|
Sign up to set email alerts
|

Mouse-protective Properties of Bordetella pertussis Serotypes in Passive Tests

Abstract: In a passive protection procedure in which the ED50 values of Bordetellc/ pertuessis antisera were determined, groups of mice were given graded intraperitoneal doses of serum, followed the next day by intracerebral challenge with 100,000 organisms. Antiserum produced with B. pertussis culture 5373, serotype 1 3, protected mice against challenge with culture 18-323, serotype 1 2. 3, as effectively as did an antiserum produced with a serotype 1 2.3 culture. When two groups of mice similarly treated with pertussi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
0
1
1

Year Published

1971
1971
1985
1985

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 15 publications
(2 citation statements)
references
References 7 publications
0
0
1
1
Order By: Relevance
“…However, Eldering et al (7,8) were not able to detect a significant difference in active or passive immunization studies with strains of different serotypes, and we, in the present report, could not show mouse protection with agglutinogen 1. However, these observations do not explain the role of these agglutinogen factors in the prophylaxis of whooping cough.…”
Section: Discussioncontrasting
confidence: 78%
“…However, Eldering et al (7,8) were not able to detect a significant difference in active or passive immunization studies with strains of different serotypes, and we, in the present report, could not show mouse protection with agglutinogen 1. However, these observations do not explain the role of these agglutinogen factors in the prophylaxis of whooping cough.…”
Section: Discussioncontrasting
confidence: 78%
“…Camundongos imunizados com fímbrias purificadas sobrevivem ao desafio contra a B. pertussis virulenta em modelo aerosol (Oda et al, 1985) e intracerebral (Eldering et al, 1967;Eldering et al, 1969). Estes dados levaram à inclusão de Fim2 e Fim 3 como antígenos em algumas novas formulações de vacinas acelulares (Locht, 1999).…”
Section: Adesinasunclassified